Three Squirrels(300783)

Search documents
本周新增三只松鼠、剑桥科技等5家企业港股发行上市获证监会备案



Sou Hu Cai Jing· 2025-10-05 06:59
Group 1 - The core point of the article is that five companies have recently received approval for overseas issuance and listing or "full circulation" of unlisted shares in China, with all listings taking place on the Hong Kong Stock Exchange [1] - The companies involved include Three Squirrels, Cambridge Technology, Jieng Electronics, and Sany Heavy Industry, all of which are already listed on the A-share market [1] - The proposed share issuances for these companies are as follows: Three Squirrels plans to issue up to 81.5483 million shares, Cambridge Technology up to 77.0620 million shares, Jieng Electronics up to 283 million shares, and Sany Heavy Industry up to 1.083 billion shares [1] Group 2 - Additionally, 52 shareholders of Baiwang Co., Ltd. intend to convert a total of approximately 13.5 million shares of unlisted domestic shares into H-shares [1]

三只松鼠H股发行上市获证监会备案
Jing Ji Guan Cha Wang· 2025-10-02 19:02
经济观察网 三只松鼠近日公告,公司于近日收到中国证监会出具的备案通知书,公司拟发行不超过 8154.83万股境外上市普通股并在香港联交所上市。公司自备案通知书出具之日起12个月内未完成境外 发行上市,拟继续推进的,应当更新备案材料。 ...
晚间公告丨9月30日这些公告有看头
第一财经· 2025-09-30 14:42
Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [4] - Bee Assistant plans to raise no more than 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [5] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Three squirrels have received approval from the China Securities Regulatory Commission for H-share issuance, with plans to issue up to 81.5483 million shares [7] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [8] Group 2 - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind, solar, and energy storage [9] - Sains plans to invest no more than 300 million yuan in the expansion of its selection agent project [10] Group 3 - Hunan YN reports no significant changes in its internal and external operating environment [11] - Electric Power Investment has had its major asset replacement review suspended by the Shenzhen Stock Exchange due to expired financial documents [12] - Guanzhong Ecological is in the planning stage for acquiring a 51% stake in Hangzhou Actuary [13][14] Group 4 - Aima Technology's subsidiary is transferring production capacity and ceasing operations due to strategic adjustments [17] - Fosun Pharma's subsidiary has received approval for clinical trials of a new drug [18] - SAIC Group's subsidiary plans to invest 666 million yuan in the restructuring of SAIC Hongyan [19] Group 5 - Hanwei Technology plans to sell 65% of Hanwei Zhiyuan for approximately 440 million yuan [20] - Xingtong Co. has been awarded new capacity for coastal inter-provincial bulk liquid hazardous goods transportation [21][22] Group 6 - EVE Battery Investment received a cash dividend of 375 million HKD from its associate company [23] - Shanmei International's chairman has resigned due to work changes [24] - Weiye Co.'s chairman has resigned for personal reasons [25] Group 7 - Jiao Da Sino's chairman has been placed under detention [26] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [27][28] - *ST Zhengping's stock has been suspended for investigation due to abnormal price fluctuations [29] Group 8 - Zhenray Technology's chairman has had detention measures lifted [30] - Shiming Technology's chairman has had detention measures changed to a warning [31] - Nanxin Pharmaceutical is under investigation by the CSRC for suspected violations in annual report disclosures [32] Group 9 - Daqian Ecology's shareholder plans to reduce holdings by up to 3% [33] - Rundar Medical's shareholders plan to reduce holdings by up to 2.99% [34][35] - Saili Medical's shareholder plans to reduce holdings by up to 2% [36] Group 10 - Huaxin Environmental plans to repurchase shares for 40 to 80 million yuan [37] - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [38] - Zhongwu Drone has signed a significant contract worth 615 million yuan for drone systems [39]
晚间公告丨9月30日这些公告有看头
Di Yi Cai Jing· 2025-09-30 11:44
Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]
三只松鼠港股IPO获中国证监会备案
Zhi Tong Cai Jing· 2025-09-30 11:36
9月30日,中国证监会国际合作司发布《关于三只松鼠(300783)股份有限公司境外发行上市备案通知书》。公司拟发行不超过81,548,274股境外上市普通股 并在香港联合交易所上市。 据招股书披露,三只松鼠是中国互联网时代诞生的"全品类+全渠道"经营模式的创新者与代表者,致力于为大众消费者提供"高端性价比"的好产品。根据灼 识咨询的数据,以2024年销售额计算,公司已从单一坚果品类发展成为中国最大的中资休闲零食企业,同时以2022年至2024年销售额年均复合增速计,公司 是行业前五大公司中增长速度最快的休闲零食企业。 | 索 引 号 | bm56000001/2025-00011539 | 分 KK | | --- | --- | --- | | 发布机构 | | 发文日期 | | 名 称 | 关于三只松鼠股份有限公司境外发行上市备案通知书 | | | 文 를 | 国合函〔2025〕 1671 号 | 主题词 | 三只松鼠的产品组合包括坚果、烘焙食品、零食组合、肉制品及干果。公司一直积极预测并回应市场需求及消费者偏好的变化,持续通过旗下多个品牌推出 新产品。截至2024年12月31日,公司提供超过1000个S ...
新股消息 | 三只松鼠港股IPO获中国证监会备案
智通财经网· 2025-09-30 11:35
智通财经APP获悉,9月30日,中国证监会国际合作司发布《关于三只松鼠股份有限公司境外发行上市备案通知书》。公司拟发行不超过81,548,274股境外上 市普通股并在香港联合交易所上市。 | 索 | bm56000001/2025-00011539 | ਸੇ | 奖 | | --- | --- | --- | --- | | 发布机构 | | 发文日期 | | | 名 称 | 关于三只松鼠股份有限公司境外发行上市备案通知书 | | | | 文 를 | 国合函〔2025〕 1671 号 | 主题词 | | 据招股书披露,三只松鼠是中国互联网时代诞生的"全品类 +全渠道"经营模式的创新者与代表者,致力于为大众消费者提供"高端性价比"的好产品。根据灼 识咨询的数据,以2024年销售额计算,公司已从单一坚果品类发展成为中国最大的中资休闲零食企业,同时以2022年至2024年销售额年均复合增速计,公司 是行业前五大公司中增长速度最快的休闲零食企业。 三只松鼠的产品组合包括坚果、烘焙食品、零食组合、肉制品及干果。公司一直积极预测并回应市场需求及消费者偏好的变化,持续通过旗下多个品牌推出 新产品。截至2024年12月31日 ...
三只松鼠:关于H股发行上市获得中国证监会备案的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-09-30 11:12
(编辑 任世碧) 证券日报网讯 9月30日晚间,三只松鼠发布公告称,公司正在申请发行H股股票并在香港联合交易所有 限公司(简称"香港联交所")主板挂牌上市(简称"本次境外发行上市")。公司于近日收到中国证券监 督管理委员会(简称"中国证监会")出具的《关于三只松鼠股份有限公司境外发行上市备案通知书》 (国合函〔2025〕1671号)(简称"备案通知书")。备案通知书主要内容如下:一、公司拟发行不超过 81,548,274股境外上市普通股并在香港联交所上市。二、自备案通知书出具之日起至本次境外发行上 市结束前,公司如发生重大事项,应根据境内企业境外发行上市有关规定,通过中国证监会备案管理信 息系统报告。三、公司完成境外发行上市后15个工作日内,应通过中国证监会备案管理信息系统报告发 行上市情况。公司在境外发行上市过程中应严格遵守境内外有关法律、法规和规则。四、公司自备案通 知书出具之日起12个月内未完成境外发行上市,拟继续推进的,应当更新备案材料。 ...
三只松鼠:H股发行上市获得中国证监会备案
Zhi Tong Cai Jing· 2025-09-30 08:28
智通财经APP讯, 三只松鼠(300783.SZ)发布公告,公司正在申请发行H股股票并在香港联合交易所有限 公司(以下简称"香港联交所")主板挂牌上市。公司于近日收到中国证券监督管理委员会(以下简称"中国 证监会")出具的《关于三只松鼠股份有限公司境外发行上市备案通知书》。 ...
三只松鼠(300783.SZ):H股发行上市获得中国证监会备案
智通财经网· 2025-09-30 08:21
智通财经APP讯, 三只松鼠(300783.SZ)发布公告,公司正在申请发行H股股票并在香港联合交易所有限 公司(以下简称"香港联交所")主板挂牌上市。公司于近日收到中国证券监督管理委员会(以下简称"中国 证监会")出具的《关于三只松鼠股份有限公司境外发行上市备案通知书》。 ...
三只松鼠:H股发行上市获中国证监会备案
Zheng Quan Shi Bao Wang· 2025-09-30 08:17
转自:证券时报 人民财讯9月30日电,三只松鼠(300783)9月30日公告,公司于近日收到中国证监会出具的备案通知书, 公司拟发行不超过8154.83万股境外上市普通股并在香港联交所上市。公司自备案通知书出具之日起12 个月内未完成境外发行上市,拟继续推进的,应当更新备案材料。 ...